Neogenomics (NEO) P/E (2011 - 2026)
Neogenomics (NEO) P/E from Mar 31, 2011 to Jun 3, 2026. The TTM Neogenomics (NEO) P/E is -2.41. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Neogenomics (NEO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.41 | -13.78% |
| 2025 | -2.80 | -47.67% |
| 2024 | -5.35 | +25.31% |
| 2023 | -4.27 | +201.51% |
| 2022 | -1.42 | -98.50% |
| 2021 | -94.63 | -128.69% |
| 2020 | 329.87 | +319.79% |
| 2019 | 78.58 | -10.52% |
| 2018 | 87.82 | -876.56% |
| 2017 | -11.31 | -91.46% |
| 2016 | -132.47 | +210.90% |
| 2015 | -42.61 | -202.22% |
| 2014 | 41.69 | +15.07% |
| 2013 | 36.23 | -44.58% |
| 2012 | 65.36 | -890.03% |
| 2011 | -8.27 | N/A |
Comparison Neogenomics (NEO) P/E with competitors
Neogenomics (NEO) P/E is -2.41.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 0.78 | -132.28% |
| MBAI | CheckCap Ltd | 2.88 | -219.40% |
| FONR | Fonar Corp | 15.41 | -738.37% |
| QGEN | Qiagen NV | 17.55 | -826.78% |
| IQV | IQVIA Holdings Inc | 20.25 | -938.70% |
| DGX | Quest Diagnostics Inc | 21.62 | -995.43% |
| LH | Laboratory Corp Of America Holdings | 22.66 | -1038.61% |
| A | Agilent Technologies Inc | 25.45 | -1154.03% |
| MEDP | Medpace Holdings Inc | 26.32 | -1190.25% |
| TMO | Thermo Fisher Scientific Inc | 26.87 | -1212.91% |
| MTD | Mettler-Toledo International Inc | 26.96 | -1216.64% |
| DHR | Danaher Corp | 33.26 | -1477.39% |
| ILMN | Illumina Inc | 34.97 | -1548.48% |
| ICLR | Icon Plc | 39.55 | -1737.86% |
| IDXX | Idexx Laboratories Inc | 40.14 | -1762.30% |
| VCYT | Veracyte Inc | 40.15 | -1763.09% |
| RVTY | Revvity Inc | 45.79 | -1996.57% |
| SHC | Sotera Health Company | 63.43 | -2727.09% |
| WAT | Waters Corp | 93.81 | -3985.29% |